Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN; Cancer Genome Atlas Research Network.

Cancer Cell. 2010 Jan 19;17(1):98-110. doi: 10.1016/j.ccr.2009.12.020.

PMID:
20129251
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Studying a complex tumor: potential and pitfalls.

Zheng S, Chheda MG, Verhaak RG.

Cancer J. 2012 Jan-Feb;18(1):107-14. doi: 10.1097/PPO.0b013e3182431c57. Review.

PMID:
22290264
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.

Karsy M, Gelbman M, Shah P, Balumbu O, Moy F, Arslan E.

Folia Neuropathol. 2012;50(4):301-21. Review.

PMID:
23319187
[PubMed - indexed for MEDLINE]
4.

Current data and strategy in glioblastoma multiforme.

Iacob G, Dinca EB.

J Med Life. 2009 Oct-Dec;2(4):386-93. Review.

PMID:
20108752
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk